HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Merav Falach-Yogev Selected Research

(N-propargyl-(3R) and (3S) aminoindan-5-yl)-ethyl methyl carbamate

10/2003The essentiality of Bcl-2, PKC and proteasome-ubiquitin complex activations in the neuroprotective-antiapoptotic action of the anti-Parkinson drug, rasagiline.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Merav Falach-Yogev Research Topics

Disease

1Alzheimer Disease (Alzheimer's Disease)
10/2003
1Neuroblastoma
10/2003
1Parkinson Disease (Parkinson's Disease)
10/2003
1Neurodegenerative Diseases (Neurodegenerative Disease)
10/2003
1Parkinsonian Disorders (Parkinsonism)
10/2003

Drug/Important Bio-Agent (IBA)

1rasagiline (Azilect)FDA Link
10/2003
1salsolineIBA
10/2003
1(N-propargyl-(3R) aminoindan-5-yl)-ethyl methyl carbamateIBA
10/2003
1(N-propargyl-(3R) and (3S) aminoindan-5-yl)-ethyl methyl carbamateIBA
10/2003
1Dopamine (Intropin)FDA LinkGeneric
10/2003
1Pharmaceutical PreparationsIBA
10/2003
1Monoamine Oxidase (MAO)IBA
10/2003
1NeurotoxinsIBA
10/2003
1Phosphotransferases (Kinase)IBA
10/2003
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
10/2003
1Amyloid beta-PeptidesIBA
10/2003
1Glutamic Acid (Glutamate)FDA Link
10/2003
1bcl-X ProteinIBA
10/2003

Therapy/Procedure

1Therapeutics
10/2003